|
1
|
Jemal A, Bray F, Center MM, Ferlay J, Ward
E and Forman D: Global cancer statistics. CA Cancer J Clin.
61:69–90. 2011. View Article : Google Scholar
|
|
2
|
Lin Y, Ueda J, Kikuchi S, et al:
Comparative epidemiology of gastric cancer between Japan and China.
World J Gastroenterol. 17:4421–4428. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Artavanis-Tsakonas S, Rand MD and Lake RJ:
Notch signaling: cell fate control and signal integration in
development. Science. 284:770–776. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Koch U and Radtke F: Notch and cancer: a
double-edged sword. Cell Mol Life Sci. 64:2746–2762. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Stanley P: Regulation of Notch signaling
by glycosylation. Curr Opin Struc Biol. 17:530–535. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Katoh M and Katoh M: Notch signaling in
gastrointestinal tract (review). Int J Oncol. 30:247–251.
2007.PubMed/NCBI
|
|
7
|
Sriuranpong V, Borges MW, Ravi RK, et al:
Notch signaling induces cell cycle arrest in small cell lung cancer
cells. Cancer Res. 61:3200–3205. 2001.PubMed/NCBI
|
|
8
|
Duan L, Yao J, Wu X and Fan M: Growth
suppression induced by Notch1 activation involves Wnt-beta-catenin
down-regulation in human tongue carcinoma cells. Biol Cell.
98:479–490. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Kunnimalaiyaan M, Vaccaro AM, Ndiaye MA
and Chen H: Overexpression of the NOTCH1 intracellular domain
inhibits cell proliferation and alters the neuroendocrine phenotype
of medullary thyroid cancer cells. J Biol Chem. 281:39819–39830.
2006. View Article : Google Scholar
|
|
10
|
Cayo MA, Cayo AK, Jarjour SM and Chen H:
Sodium butyrate activates Notch1 signaling, reduces tumor markers,
and induces cell cycle arrest and apoptosis in pheochromocytoma. Am
J Transl Res. 1:178–183. 2009.PubMed/NCBI
|
|
11
|
Greblatt DY, Vaccaro AM, Jaskula-Sztul R,
et al: Valproic acid activates notch-1 signaling and regulates the
neuroendocrine phenotype in carcinoid cancer cells. Oncologist.
12:942–951. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Kim SB, Chae GW, Lee J, et al: Activated
Notch1 interacts with p53 to inhibit its phosphorylation and
transactivation. Cell Death Differ. 14:982–991. 2007.PubMed/NCBI
|
|
13
|
Ning L, Wentworth L, Chen H and Weber SM:
Down-regulation of Notch1 signaling inhibits tumor growth in human
hepatocellular carcinoma. Am J Transl Res. 1:358–366.
2009.PubMed/NCBI
|
|
14
|
Tanaka M, Setoguchi T, Hirotsu M, et al:
Inhibition of Notch pathway prevents osteosarcoma growth by cell
cycle regulation. Br J Cancer. 100:1957–1965. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Guo D, Ye J, Dai J, et al: Notch-1
regulates Akt signaling pathway and the expression of cell cycle
regulatory proteins cyclin D1, CDK2 and p21 in T-ALL cell lines.
Leuk Res. 33:678–685. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Massi D, Tarantini F, Franchi A, et al:
Evidence for differential expression of Notch receptors and their
ligands in melanocytic nevi and cutaneous malignant melanoma. Mod
Pathol. 19:246–254. 2006. View Article : Google Scholar
|
|
17
|
Tarakji B and Nassani MZ:
Immunohistochemical expression of p21 in normal tissues of salivary
gland, pleomorphic adenoma and carcinoma ex pleomorphic
adenoma-(undifferentiated and adenocarcinoma types). Med Oral Patol
Oral Cir Bucal. 15:e697–e703. 2010. View Article : Google Scholar
|
|
18
|
De La OJP, Emerson LL, Goodman JL, et al:
Notch and Kras reprogram pancreatic acinar cells to ductal
intraepithelial neoplasia. Proc Natl Acad Sci USA. 105:18907–18912.
2008.PubMed/NCBI
|
|
19
|
Fre S, Huyghe M, Mourikis P, et al: Notch
signals control the fate of immature progenitor cells in the
intestine. Nature. 435:964–968. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Fan X, Matsui W, Khaki L, et al: Notch
pathway inhibition depletes stem-like cells and blocks engraftment
in embryonal brain tumors. Cancer Res. 66:7445–7452. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Yeh TS, Wu CW, Hsu KW, et al: The
activated Notch1 signal pathway is associated with gastric cancer
progression through cyclooxygenase-2. Cancer Res. 69:5039–5048.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Garcia TX, Defalco T, Capel B and Hofmann
MC: Constitutive activation of NOTCH1 signaling in Sertoli cells
causes gonocyte exit from quiescence. Dev Biol. 377:188–201. 2013.
View Article : Google Scholar
|
|
23
|
Piccin D, Yu F and Morshead C: Notch
signaling imparts and preserves neural stem characteristics in the
adult brain. Stem Cells Dev. 22:1541–1550. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Giambra V, Jenkins CR, Wang H, et al:
NOTCH1 promotes T cell leukemia-initiating activity by
RUNX-mediated regulation of PKC-θ and reactive oxygen species. Nat
Med. 18:1693–1698. 2012.PubMed/NCBI
|
|
25
|
Simmons MJ, Serra R, Hermance N and
Kelliher MA: NOTCH1 inhibition in vivo results in mammary tumor
regression and reduced mammary tumorsphere-forming activity in
vitro. Breast Cancer Res. 14:R1262012. View
Article : Google Scholar : PubMed/NCBI
|
|
26
|
Fassl A, Tagscherer KE, Richter J, et al:
Notch1 signaling promotes survival of glioblastoma cells via
EGFR-mediated induction of anti-apoptotic Mcl-1. Oncogene.
31:4698–4708. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Skirnisdottir I and Seidal T: Association
of p21, p21 p27 and p21 p53 status to histological subtypes and
prognosis in low-stage epithelial ovarian cancer. Cancer Genomics
Proteomics. 10:27–34. 2013.PubMed/NCBI
|
|
28
|
Place RF, Wang J, Noonan EJ, et al:
Formulation of small activating RNA into lipidoid nanoparticles
inhibits xenograft prostate tumor growth by inducing p21
expression. Mol Ther Nucleic Acids. 1:e152012. View Article : Google Scholar
|
|
29
|
Jee H, Lee SH, Park JW, et al: Connexin32
inhibits gastric carcinogenesis through cell cycle arrest and
altered expression of p21Cip1 and p27Kip1. BMB Rep. 46:25–30. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Rowland BD and Peeper DS: KLF4, p21 and
context-dependent opposing forces in cancer. Nat Rev Cancer.
6:11–23. 2006. View
Article : Google Scholar : PubMed/NCBI
|
|
31
|
Devgan V, Mammucari C, Millar SE, et al:
p21WAF1/Cip1 is a negative transcriptional regulator of Wnt4
expression downstream of Notch1 activation. Genes Dev.
19:1485–1495. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Götte M, Greve B, Kelsch R, et al: The
adult stem cell marker Musashi-1 modulates endometrial carcinoma
cell cycle progression and apoptosis via Notch-1 and p21WAF1/CIP1.
Int J Cancer. 129:2042–2049. 2011.PubMed/NCBI
|
|
33
|
Sarmento LM, Huang H, Limon A, et al:
Notch1 modulates timing of G1-S progression by inducing SKP2
transcription and p27 Kip1 degradation. J Exp Med. 202:157–168.
2005. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Li DW, Wu Q, Peng ZH, et al: Expression
and significance of Notch1 and PTEN in gastric cancer. Ai Zheng.
26:1183–1187. 2007.(In Chinese).
|
